Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

6.9%

2 terminated out of 29 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed with results

Key Signals

1 with results86% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (3)
P 1 (2)
P 2 (3)
P 4 (2)

Trial Status

Completed12
Unknown6
Recruiting6
Not Yet Recruiting2
Terminated2
Active Not Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT06258525Phase 2Not Yet Recruiting

SAMe in Prevention of Oxaliplatin-associated Liver Injury

NCT06910943Phase 2Recruiting

Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support

NCT04937868Recruiting

Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients

NCT07277192Completed

HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival

NCT05155358Not Yet Recruiting

Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke

NCT07050550RecruitingPrimary

A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver Injury

NCT06670391Active Not RecruitingPrimary

A Retrospective Study in Patients With Liver Injury After the Use of Novel Antineoplastic Agents

NCT06864481RecruitingPrimary

Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

NCT05882214Phase 1Completed

Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink

NCT06298318Phase 1Completed

Metabolic Changes in Healthy Subjects with Acute Binge Drink

NCT04004884Terminated

Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine Fibroids (LISA)

NCT06402981Recruiting

A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients

NCT06080308RecruitingPrimary

Liver Ischemia-reperfusion Injury and Clinical Data Analysis

NCT06244550Not ApplicableCompleted

Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors

NCT06249646Completed

Contained Hepatic Vascular Injuries Following Liver Trauma

NCT05229328Unknown

Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis

NCT04934384Completed

The Role of Prehospital eFAST in Accelerating Time to Diagnostics or Definitive Treatment in the Emergency Department

NCT04358380UnknownPrimary

Liver Injury in Patients With COVID-19

NCT04257240Completed

Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury

NCT03960710Unknown

Automatic Segmentation of Polycystic Liver

Scroll to load more

Research Network

Activity Timeline